Marpai (NASDAQ:MRAI) Issues Quarterly Earnings Results

Marpai (NASDAQ:MRAI) announced its quarterly earnings results on Tuesday. The company reported ($0.65) earnings per share for the quarter, reports. The firm had revenue of $8.71 million for the quarter. Marpai had a negative net margin of 77.38% and a negative return on equity of 789.96%.

Marpai Stock Performance

Shares of NASDAQ MRAI opened at $2.08 on Thursday. Marpai has a 12 month low of $0.33 and a 12 month high of $13.60. The firm has a fifty day simple moving average of $1.63 and a two-hundred day simple moving average of $1.31.

Insiders Place Their Bets

In related news, CEO Damien Lamendola acquired 910,000 shares of the firm’s stock in a transaction on Thursday, March 7th. The stock was acquired at an average cost of $1.65 per share, for a total transaction of $1,501,500.00. Following the acquisition, the chief executive officer now owns 2,861,306 shares of the company’s stock, valued at $4,721,154.90. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. In the last ninety days, insiders purchased 2,022,100 shares of company stock worth $2,524,632. 61.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Marpai stock. Jane Street Group LLC acquired a new stake in shares of Marpai, Inc. (NASDAQ:MRAI) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 15,586 shares of the company’s stock, valued at approximately $28,000. Jane Street Group LLC owned approximately 0.08% of Marpai as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 49.75% of the company’s stock.

About Marpai

Marpai, Inc, a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services.